Short rare minisatellite variant of BORIS-MS2 is related to bladder cancer susceptibility.

Tae Nam KimWon-Tae KimMi-So JeongMi-Hye MunMin-Hye KimJeong Zoo LeeSun-Hee Leem

Published in: Genes & genomics (2018)

The short rare allele of BORIS-MS2 could be used to identify bladder cancer risk. BORIS expression levels have been shown to increase with the progression of bladder cancer, could be used as a biomarker for its progression.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
poor prognosis
spinal cord injury
long non coding rna